New concepts for future control of HIV derived from studies of pathogenesisGALLO, Robert C.International journal of antimicrobial agents. 2000, Vol 16, Num 4, pp 421-423, issn 0924-8579Conference Paper

The discovery of HIV as the cause of AIDSGALLO, Robert C; MONTAGNIER, Luc.The New England journal of medicine. 2003, Vol 349, Num 24, pp 2283-2285, issn 0028-4793, 3 p.Article

Anti-cytokine Ab immune therapy: present status and perspectivesZAGURY, Daniel; GALLO, Robert C.Drug discovery today. 2004, Vol 9, Num 2, pp 72-81, issn 1359-6446, 10 p.Article

AIDS viewpointsPRUSINER, Stanley B; MONTAGNIER, Luc; GALLO, Robert C et al.Science (Washington, D.C.). 2002, Vol 298, Num 5599, pp 1726-1731, issn 0036-8075, 6 p.Article

Human retroviruses after 20 years: a perspective from the past and prospects for their future controlGALLO, Robert C.Immunological reviews. 2002, Vol 185, pp 236-265, issn 0105-2896, 30 p.Article

History of the discoveries of the first human retroviruses : HTLV-1 and HTLV-2GALLO, Robert C.Oncogene (Basingstoke). 2005, Vol 24, Num 39, pp 5926-5930, issn 0950-9232, 5 p.Article

HIV receptors on lymphocytesGARZINO-DEMO, Alfredo; GALLO, Robert C.Current opinion in hematology. 2003, Vol 10, Num 4, pp 279-283, issn 1065-6251, 5 p.Article

Frontiers in human retrovirology and related topics : abstracts, August 11-17, 1990, Besthesda MAGALLO, Robert C.AIDS research and human retroviruses. 1991, Vol 7, Num 2, issn 0889-2229, 259 p.Conference Proceedings

Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5KISH-CATALONE, Tina M; WUYUAN LU; GALLO, Robert C et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1497-1509, issn 0066-4804, 13 p.Article

Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonistsLATINOVIC, Olga; HEREDIA, Alonso; GALLO, Robert C et al.Antiviral research. 2009, Vol 83, Num 1, pp 86-89, issn 0166-3542, 4 p.Article

Increased Interferon Alpha Expression in Circulating Plasmacytoid Dendritic Cells of HIV-1-Infected PatientsLEHMANN, Clara; HARPER, Jill M; TAUBERT, Dirk et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 5, pp 522-530, issn 1525-4135, 9 p.Article

The role of chemokines in human immunodeficiency virus infectionGARZINO-DEMO, Alfredo; DEVICO, Anthony L; CONANT, Katherine E et al.Immunological reviews. 2000, Vol 177, pp 79-87, issn 0105-2896Article

A sound rationale needed for phase III HIV-1 vaccine trialsBURTON, Dennis R; DESROSIERS, Ronald C; LEDERMAN, Michael M et al.Science (Washington, D.C.). 2004, Vol 303, Num 5656, issn 0036-8075, p. 316Article

Differential polarization of immune responses by co-administration of antigens with chemokinesFRAUENSCHUH, Achim; DEVICO, Anthony L; SIEW PHENG LIM et al.Vaccine. 2004, Vol 23, Num 4, pp 546-554, issn 0264-410X, 9 p.Article

Annual meeting of the Laboratory of Tumor Cell Biology, National Cancer Institute: abstracts, August 20-26, 1989, Bethesda MDGALLO, Robert C; NERURKAR, Lata S; BOLOGNESI, Dari P et al.AIDS research and human retroviruses. 1990, Vol 6, Num 1, issn 0889-2229, 2 p. non paginées, 1-171 [173 p.]Conference Proceedings

De l'intérêt d'une vaccination thérapeutique chez des patients infectés par le VIH sous traitement antirétroviralBURNY, Arsene; CLUMECK, Nathan; HERMANS, Philippe et al.Bulletin de l'Académie nationale de médecine. 2006, Vol 190, Num 9, pp 1897-1901, issn 0001-4079, 5 p.Conference Paper

Identification of factors that govern HIV-1 replication in nondividing host cellsSTEVENSON, M.AIDS research and human retroviruses. 1994, Vol 10, pp S11-S15, issn 0889-2229, SUP1Conference Paper

Programmed cell death (apoptosis) and AIDS pathogenesisAMEISEN, J. C.AIDS research and human retroviruses. 1994, Vol 10, pp S3-S5, issn 0889-2229, SUP1Conference Paper

CCR5 density levels on primary CD4 T cells impact the replication and enfuvirtide susceptibility of R5 HIV-1HEREDIA, Alonso; GILLIAM, Bruce; DEVICO, Anthony et al.AIDS (London). 2007, Vol 21, Num 10, pp 1317-1322, issn 0269-9370, 6 p.Article

Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitroHEREDIA, Alonso; GILLIAM, Bruce; LATINOVIC, Olga et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2489-2496, issn 0066-4804, 8 p.Article

Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replicationHEREDIA, Alonso; DAVIS, Charles; BAMBA, Douty et al.AIDS (London). 2005, Vol 19, Num 18, pp 2087-2095, issn 0269-9370, 9 p.Article

Modern trends in human Leukemia VIII: new results in clinical and biological research including pediatric oncology, Hamburg, June 18, 1988, Wilsede June 19-23, 1988 and Hamburg, June 17, 1988NETH, Rolf; GALLO, Robert C; GREAVES, Melvyn F et al.Haematology and blood transfusion. 1989, Num 32, issn 0171-7111, LVII-532 p. [589 p.]Conference Proceedings

Les kinoïdes : Une nouvelle génération de vaccins thérapeutiques = Kinoids: a novel generation of specific immune therapy against cytokinesBENSUSSAN, Armand; BIZZINI, Bernard; POULETTY, Philippe et al.MS. Médecine sciences. 2008, Vol 24, Num 3, pp 306-313, issn 0767-0974, 8 p.Article

Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat proteinRUCKWARDT, Tracy J; TIKHONOV, Ilia; BERG, Shannon et al.Journal of virology. 2004, Vol 78, Num 23, pp 13190-13196, issn 0022-538X, 7 p.Article

SIV transmission across the mucosal barrierPAUZA, C. D; MALKOVSKY, M; SALVATO, M. S et al.AIDS research and human retroviruses. 1994, Vol 10, pp S7-S10, issn 0889-2229, SUP1Conference Paper